Accendra Health vs AdaptHealth
ACH and AHCO side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ACH and AHCO compare
AdaptHealth is the larger company, worth 105 times as much as Accendra Health ($1.1B against $10.0M).
AdaptHealth grew revenue faster over the last twelve months (4.2% versus −7.1% for Accendra Health).
Accendra Health keeps more of each dollar of sales as profit, with a net margin of −6.7% compared with −7.1% at AdaptHealth.
AdaptHealth scores higher on the StockData Score (6 against 5 for Accendra Health), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ACH | AHCO |
|---|---|---|
| Size and price | ||
| Market cap | $10.0M | $1.1B |
| Share price | $0.130 | $7.73 |
| Change, 1 year | −95.6% | −17.1% |
| Change, 5 years | −99.7% | −64.2% |
| Beta (5Y) | – | −1.50 |
| Employees | 6,500 | 11K |
| StockData Score | ||
| Total score | 5 | 6 (better) |
| Valuation score | 4 (better) | 3 |
| Growth score | 0 | 0 |
| Performance score | 1 (better) | 0 |
| Health score | 0 | 3 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.0× (better) | 0.3× |
| P/B | – | 0.8× |
| EV/EBITDA | 7.4× (better) | 10.6× |
| P/FCF | – | 10.8× |
| FCF yield | −1992% | 9.3% (better) |
| Fair value | $8.62 | $13.53 |
| Margin of safety | 98.5% (better) | 42.9% |
| Growth | ||
| Revenue growth (TTM) | −7.1% | 4.2% (better) |
| Revenue growth, 5Y average | −20.1% | 25.2% (better) |
| Net income growth (TTM) | – | −383% |
| EPS growth (TTM) | – | −419% |
| Profitability | ||
| Gross margin | 44.1% (better) | 17.0% |
| Operating margin | 0.17% (better) | −4.5% |
| Net margin | −6.7% (better) | −7.1% |
| FCF margin | −7.8% | 3.0% (better) |
| Return on equity | – | −15.4% |
| Return on invested capital | 0.24% (better) | −3.4% |
| Financial health | ||
| Debt / equity | – | 1.37 |
| Net debt / EBITDA | 7.35 | 6.79 (better) |
| Interest coverage | 0.0× | – |
| Current ratio | 0.41 | 1.12 (better) |
| Altman Z-score | 0.20 | 0.62 (better) |
| Piotroski F-score | 2 | 4 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 81.1% | 104% |
| Held by insiders | 21.4% | 14.7% |
| Insider net buying, 12 months | – | $49.1M |
| Short interest, % of float | 16.8% | 9.4% |
Go deeper
- ACH stock overview
- ACH income statement
- ACH valuation and score
- AHCO stock overview
- AHCO income statement
- AHCO valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.